People Background Check
Find People:

Edward A Burg, Age 88Riviera Beach, MD

Get Report
Known as:
Ed A Burg
Related to:
Danielle F Quigley 32 Linda J Cain

Edward Burg Phones & Addresses

Pasadena, MD

Curtis Bay, MD

Work

Company: Manatt, Phelps & Phillips, LLP Address:

Mentions for Edward A Burg

Career records & work history

Lawyers & Attorneys

Edward Burg Photo 1

Edward Burg - Lawyer

Office:
Manatt, Phelps & Phillips, LLP
Specialties:
Eminent Domain Litigation, Energy & Natural Resources, Government Civil and Administrative Litigation, Infrastructure, Litigation, Real Estate Litigation, International Law
ISLN:
908676178
Admitted:
1982
University:
University of California, Irvine, B.A., 1979
Law School:
University of California, Berkeley, Boalt Hall School of Law, J.D.; University of California, Berkeley, Boalt Hall School of Law, J.D.; University of California, Berkeley, Boalt Hall School of Law, J.D.

License Records

Edward J Burg

Licenses:
License #: 7017541 - Active
Category: EMS Licensing
Issued Date: Nov 9, 2015
Expiration Date: Jun 30, 2018
Type: EMT-Paramedic

Publications & IP owners

Us Patents

Combinant Polypeptide For Use In The Manufacture Of Vaccines Against Induced Diarrhea And To Reduce Colonization

US Patent:
6987176, Jan 17, 2006
Filed:
Nov 12, 1999
Appl. No.:
09/439311
Inventors:
Patricia Guerry - Silver Spring MD, US
Lanfong H. Lee - Silver Spring MD, US
Edward Burg - Manassas VA, US
Trevor J. Trust - Sherborn MA, US
Assignee:
The United States of America as represented by the Secretary of the Navy - Washington DC
International Classification:
C07H 21/02
US Classification:
536 231, 536 234, 536 237, 514 44, 530825, 530403, 435 6, 435 911, 435 711, 435 691, 435 712, 4352523, 4352528, 4353201
Abstract:
This invention comprises a recombinant protein comprising the maltose binding protein (MBP) of fused to amino acids 5–337 of the FlaA flagellin of VC167 which has provided evidence of immunogenicity and protective efficacy against challenge by a heterologous strain of 81–176 in mammals. The invention further comprises a recombinant DNA construct encoding the immunodominant region (region I through III) of flagellin from spp. for use as a component of a vaccine against diarrhea. The invention therefore represents an effective treatment against but avoids inducing the autoimmune Guillain Barre Syndrome (GBS), a post-infection polyneuropathy caused by molecular mimicry of human gangliosides which has hampered the development of vaccines heretofore.

Possible Relatives

David R Burg  Aaron L Burg  Diana G Burg  Donald A Burg  Donna R Burg  Elaine Burg  Emily D Burg  Edward H Standish  Edward L Stanford  Edward K Jolly 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.